Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liz Lightstone

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 18, 2023
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trialHans-Joachim Anders, Richard Furie, Ana Malvar, et al.
Annals of the Rheumatic Diseases|August 7, 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive SummaryCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: replyCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Clinical and Experimental Rheumatology|January 5, 2026
High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosusYun-Ju Huang, Charlotte M Bottomley, Robert T Maughan, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
JCI Insight|June 2, 2026
Mapping the plasma proteomic architecture of systemic lupus erythematosusGeoffrey H D Leung, Charlotte Bottomley, Norzawani Buang, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 18, 2023
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trialHans-Joachim Anders, Richard Furie, Ana Malvar, et al.
Annals of the Rheumatic Diseases|August 7, 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|October 14, 2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive SummaryCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: replyCaroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Clinical and Experimental Rheumatology|January 5, 2026
High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosusYun-Ju Huang, Charlotte M Bottomley, Robert T Maughan, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
JCI Insight|June 2, 2026
Mapping the plasma proteomic architecture of systemic lupus erythematosusGeoffrey H D Leung, Charlotte Bottomley, Norzawani Buang, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Pageof 12